-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Truist Financial Reaffirms Buy Rating for Viking Therapeutics (NASDAQ:VKTX)
Truist Financial reaffirmed their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report released on Monday, Marketbeat.com reports. The firm currently has a $75.00 target price on the biotechnology company’s stock, down from their previous target price of $95.00. A number of other analysts have also recently weighed in on […]
Truist Financial reaffirmed their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report released on Monday, Marketbeat.com reports. The firm currently has a $75.00 target price on the biotechnology company’s stock, down from their previous target price of $95.00. A number of other analysts have also recently weighed in on […]
